Back to search

Italy· 039655028

PROLIZIP*orale sosp 1 flacone 60 ml 250 mg/5 ml

A cefprozil product containing cefprozil, registered in Italy by FARTO Srl, on the national reimbursement list. The same ATC class is registered in 6 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC J01DC10

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedPROLIZIP*orale sosp 1 flacone 60 ml 2…ATCJ01DC10REGISTER NO.039655028PACKS LISTED1CHECKEDJune 4, 2026

Where it is registered

Cefprozil is registered in 6 of 19 countries.

Countries holding a registration under ATC J01DC10 (cefprozil), each read from that country’s own register.

  • This record: Italy
  • 4 of them publish a price we can compare per daily dose

Cefprozil · ATC J01DC10

6 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Italyprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefprozil costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

  • Italy: $3.28 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Cefprozil · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • IT Italy$3.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Active substance
Cefprozil
Manufacturer
FARTO Srl
Country
Italy (IT)
ATC code
J01DC10
ATC class
Cefprozil
Defined daily dose
1 g, O
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    039655028
    PROLIZIP*orale sosp 1 flacone 60 ml 250 mg/5 ml
    EUR 8.88

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for cefprozil.

Graded by severity as the source publishes them — 21 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cefprozil · interactions on record

81 records

  • 21 moderate
  • 60 info

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • NeomycinA07AA01moderate
  • StreptomycinA07AA04moderate
  • KanamycinA07AA08moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefprozil in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefprozil products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Bulgaria · Профикс, Цефзил
  • Czechia · Cefzil, Cefzil O.S.
  • Estonia · Cefzil
  • Greece · Cefgram, Cefpro
  • Hungary · Cefzil
  • Lithuania · Cefzil
  • Latvia · Cefzil
  • Portugal · Procef
  • Slovenia · Cefzil
  • Slovakia · Cefzil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/38c1643a-1518-4320-9e6c-f19854e1c4f5
GET /v1/drugs/38c1643a-1518-4320-9e6c-f19854e1c4f5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 8.88,
  "source": "aifa",
  "currency": "EUR",
  "strength": "CEFPROZIL 250MG/5ML USO ORALE",
  "substance": "Cefprozil",
  "equivalence_group": "IZA",
  "transparency_flag": null
}

See everything about cefprozil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.